Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,615
Closed -$317K 3
2020
Q3
$317K Buy
3,615
+306
+9% +$28.8K 0.23% 203
2020
Q2
$325K Sell
3,309
-23
-0.7% -$2.02K 0.25% 186
2020
Q1
$254K Sell
3,332
-124
-4% -$10.6K 0.23% 183
2019
Q4
$306K Sell
3,456
-60
-2% -$4.98K 0.2% 211
2019
Q3
$266K Sell
3,516
-104
-3% -$7.13K 0.18% 222
2019
Q2
$243K Buy
3,620
+1,101
+44% +$86.5K 0.16% 239
2019
Q1
$203K Buy
2,519
+6
+0.2% +$491 0.14% 249
2018
Q4
$232K Sell
2,513
-951
-27% -$83.6K 0.17% 213
2018
Q3
$328K Sell
3,464
-89
-3% -$8.44K 0.2% 199
2018
Q2
$329K Sell
3,553
-119
-3% -$11.6K 0.2% 191
2018
Q1
$348K Sell
3,672
-332
-8% -$36.5K 0.22% 181
2017
Q4
$387K Sell
4,004
-495
-11% -$46.7K 0.23% 172
2017
Q3
$400K Sell
4,499
-142
-3% -$10.8K 0.25% 164
2017
Q2
$337K Sell
4,641
-198
-4% -$13.3K 0.22% 183
2017
Q1
$315K Buy
4,839
+7
+0.1% +$440 0.21% 185
2016
Q4
$303K Buy
4,832
+285
+6% +$17.4K 0.2% 187
2016
Q3
$287K Buy
4,547
+15
+0.3% +$971 0.2% 186
2016
Q2
$281K Sell
4,532
-792
-15% -$48.3K 0.2% 187
2016
Q1
$304K Sell
5,324
-113
-2% -$6.3K 0.22% 173
2015
Q4
$322K Buy
5,437
+103
+2% +$5.93K 0.24% 169
2015
Q3
$290K Sell
5,334
-136
-2% -$8.85K 0.21% 176
2015
Q2
$368K Sell
5,470
-282
-5% -$18.4K 0.25% 164
2015
Q1
$337K Sell
5,752
-6,812
-54% -$412K 0.22% 173
2014
Q4
$822K Sell
12,564
-1,463
-10% -$92.2K 0.54% 13
2014
Q3
$810K Sell
14,027
-220
-2% -$12.2K 0.57% 13
2014
Q2
$804K Buy
14,247
+8,533
+149% +$448K 0.54% 13
2014
Q1
$294K Sell
5,714
-6
-0.1% -$303 0.2% 174
2013
Q4
$302K Buy
5,720
+69
+1% +$3.39K 0.21% 180
2013
Q3
$253K Buy
5,651
+56
+1% +$2.48K 0.19% 185
2013
Q2
$231K Buy
+5,595
New +$245K 0.18% 192

Other funds holding ABBV

Alpha Windward's ABBV Position: Q4 2020 in Review

Alpha Windward sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 3,615 shares — an estimated $317K sold.

Alpha Windward first reported a position in ABBV in Q2 2013 and held it in 30 quarters. The position peaked at $822K in Q4 2014. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Alpha Windward reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Alpha Windward sold 3,615 AbbVie shares in Q4 2020, an estimated $317K.
  • Alpha Windward first reported a position in AbbVie in Q2 2013 and held it in 30 quarters.
  • Alpha Windward's AbbVie position peaked at $822K in Q4 2014.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.